MarketCap
Facebook
X
TelegramQuarterly report 2025-Q1
added 04-22-2025
Danaher Corporation DIO Ratio 2011-2026 | DHR
Annual DIO Ratio Danaher Corporation
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 92.9 | 99.2 | 96.6 | 96.5 | 72.9 | 75 | 79.4 | 82.6 | 82.7 | 78 | 70.6 | 71.1 | 74.8 | 82.2 |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 99.2 | 70.6 | 82.5 |
Quarterly DIO Ratio Danaher Corporation
| 2025-Q1 | 2024-Q4 | 2024-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 99.5 | - | - | - | - | 95.3 | 89.3 | - | - | 44.8 | 88.6 | - | - | - | 39.1 | - | - | - | 39.9 | - | - | - | 40.9 | - | 84.4 | 80 | 84.7 | - | 84.5 | 83.8 | 85.2 | - | 103 | 82.5 | 79.5 | - | 73.1 | 71.3 | 73.6 | - | 72.5 | 72.6 | 77.5 | - | 77.4 | 75.3 | 78.8 | - | 71.8 | 94.6 | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 103 | 39.1 | 76.6 |
DIO Ratio of other stocks in the Diagnostics research industry
| Issuer | DIO Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Centogene N.V.
CNTG
|
25.4 | - | -6.23 % | $ 30.6 M |  Germany |
 |
Aspira Women's Health
AWH
|
23.1 | - | -6.19 % | $ 10.5 M |  USA |
 |
Accelerate Diagnostics
AXDX
|
198 | - | -61.36 % | $ 2.46 M | USA |
 |
Burning Rock Biotech Limited
BNR
|
243 | $ 29.14 | -3.75 % | $ 326 M |  China |
 |
Biocept
BIOC
|
21.9 | - | -13.05 % | $ 7.29 M | USA |
 |
BioNano Genomics
BNGO
|
245 | $ 1.1 | 0.46 % | $ 1.4 M | USA |
 |
Oxford Immunotec Global PLC
OXFD
|
210 | - | - | $ 562 M |  Britain |
 |
Co-Diagnostics
CODX
|
304 | - | - | $ 79.8 M | USA |
 |
DarioHealth Corp.
DRIO
|
165 | $ 11.38 | 1.16 % | $ 323 M |  Israel |
 |
DexCom
DXCM
|
115 | $ 70.29 | 8.0 % | $ 27.4 B | USA |
 |
Chembio Diagnostics
CEMI
|
97.6 | - | 0.22 % | $ 16.8 M | USA |
 |
Castle Biosciences
CSTL
|
48.7 | $ 32.89 | 3.09 % | $ 914 M | USA |
 |
Quest Diagnostics Incorporated
DGX
|
10.4 | $ 205.13 | -0.82 % | $ 22.8 B | USA |
 |
Global Cord Blood Corporation
CO
|
89.7 | - | - | $ 399 M | China |
 |
Fluidigm Corporation
FLDM
|
131 | - | 1.08 % | $ 308 M | USA |
 |
Genetic Technologies Limited
GENE
|
42.1 | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
62.8 | - | 0.12 % | $ 80.1 M | China |
 |
Fulgent Genetics
FLGT
|
7.17 | $ 23.24 | 1.18 % | $ 703 M | USA |
 |
Enzo Biochem
ENZ
|
156 | - | -8.98 % | $ 14.8 K | USA |
 |
CareDx, Inc
CDNA
|
48.3 | $ 19.6 | 2.62 % | $ 1.05 B | USA |
 |
DermTech
DMTK
|
33.5 | - | -11.32 % | $ 2.94 M | USA |
 |
Interpace Biosciences
IDXG
|
26.2 | $ 1.85 | - | $ 8.12 M | USA |
 |
Exact Sciences Corporation
EXAS
|
240 | $ 103.32 | 0.09 % | $ 19.1 B | USA |
 |
Heska Corporation
HSKA
|
137 | - | - | $ 1.31 B | USA |
 |
Lantheus Holdings
LNTH
|
44.2 | $ 68.71 | -0.02 % | $ 4.75 B | USA |
 |
Guardant Health
GH
|
78.4 | $ 104.76 | 1.95 % | $ 12.9 B | USA |
 |
QIAGEN N.V.
QGEN
|
141 | - | - | $ 10.6 B |  Niderland |
 |
HTG Molecular Diagnostics
HTGM
|
116 | - | -20.0 % | $ 1.06 M | USA |
 |
Charles River Laboratories International
CRL
|
35.3 | $ 160.2 | 0.91 % | $ 8.23 B | USA |
 |
IDEXX Laboratories
IDXX
|
91.6 | $ 627.58 | 1.68 % | $ 51.8 B | USA |
 |
Illumina
ILMN
|
137 | $ 115.9 | 1.27 % | $ 18.4 B | USA |
 |
OPKO Health
OPK
|
45.2 | $ 1.24 | 2.48 % | $ 861 M | USA |
 |
Natera
NTRA
|
25.8 | $ 204.66 | -1.53 % | $ 20.1 B | USA |
 |
Koninklijke Philips N.V.
PHG
|
89 | $ 31.11 | -0.94 % | $ 20 B | Niderland |
 |
Personalis
PSNL
|
12.1 | $ 8.22 | -2.09 % | $ 487 M | USA |
 |
Laboratory Corporation of America Holdings
LH
|
18.8 | $ 281.39 | 1.13 % | $ 23.6 B | USA |
 |
ICON Public Limited Company
ICLR
|
0.213 | $ 95.34 | 19.06 % | $ 7.86 B |  Irlanda |
 |
Quidel Corporation
QDEL
|
133 | $ 23.61 | -0.55 % | $ 995 M | USA |
 |
Biomerica
BMRA
|
147 | $ 2.25 | 4.19 % | $ 5.17 M | USA |
 |
Bioventus
BVS
|
175 | $ 8.22 | 1.48 % | $ 515 M | USA |